Developer docs
API playgroundTry for free, no card

Search company profiles

Diligent Pharma

Full company profile

uuid0000qte

Namestring
Diligent Pharma
Legal namestring
Diligent Pharma Inc.
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Diligent Pharma is a Philadelphia- and Princeton, NJ-based private software company founded in 2018 that operates a centralized vendor qualification platform for the clinical trial industry. The company's core product, Diligent360, connects pharmaceutical sponsors and clinical trial vendors, streamlining risk-based vendor discovery, qualification, and monitoring. It is supplemented by VendorBase, a global database of clinical vendors with data on capabilities, experience, qualification, and compliance, and Diligent Respond, an automated questionnaire tool that helps vendors complete RFI forms faster while demonstrating ICH and regulatory compliance. SME-led risk scoring and a regulation-based RFI and Audit Report Library are positioned as the primary differentiators, with the company claiming reduction of vendor qualification timelines from months to days and significant audit hours saved for clients since 2021.

The business operates as an enterprise SaaS on a subscription/recurring revenue model, selling directly to pharmaceutical sponsors and clinical trial vendors through a 'Book a Demo' sales motion that signals quote-based, large-ACV contracts rather than self-serve SMB volume. Pricing is not publicly disclosed. The customer base is segmented vertically — sponsors seeking to mitigate trial risk and shorten start-up timelines, and vendors seeking faster qualification and broader sponsor exposure — addressing pain points such as lengthy qualification cycles, fragmented vendor oversight, and compliance with ICH and global regulatory standards. The company maintains a content marketing and blog presence for top-of-funnel engagement and funnels prospects into demo-driven bottom-of-funnel conversions.

Diligent Pharma completed an $8.27 million Series A financing round in May 2023 led by FCA Venture Partners, with additional participation from PJC and GenHenn Capital. The funding was directed toward expanding the company's data and content strategy for streamlining vendor qualification in clinical trial execution. The company operates with 11-50 employees, is led by founder Patricia Leuchten and President LeRoy Jones, and is incorporated as Diligent Pharma Inc. in the United States. No revenue, ARR, or named customer logos are publicly disclosed.

Short descriptiontext

Diligent Pharma operates Diligent360, a centralized SaaS platform that connects pharmaceutical sponsors and clinical trial vendors for risk-based vendor discovery, qualification, and monitoring, supported by VendorBase (a global vendor database) and Diligent Respond (automated RFI questionnaire tool).

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPrinceton, United States
HQ citystring
Princeton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial vendor qualification, clinical trial management software, pharmaceutical vendor management, clinical vendor database, RFI management software
Industry2 codes
PRIMARYHLAGAOAH
Clinical Trial Supply, Logistics & Vendor Management FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Management Software
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Platform Subscription
TypeSubscription Recurring
Description

SaaS-based platform access for sponsors and vendors. The company operates as a private vendor qualification organization providing centralized vendor management solutions for clinical trial management.

diligentpharma.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Diligent360
Description

Centralized platform that connects Sponsor and Vendors, streamlining risk-based Vendor discovery, qualification, and monitoring for clinical trials

diligentpharma.com
+2 more records
Core offering1 text field

Diligent Pharma provides a centralized SaaS platform (Diligent360) that connects pharmaceutical sponsors and clinical trial vendors, streamlining risk-based vendor discovery, qualification, and monitoring for clinical trials. The offering is complemented by VendorBase, a global database of clinical vendors with capabilities and compliance data, and Diligent Respond, an automated questionnaire tool that helps vendors complete RFI forms faster.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 3-5 months reduction in qualification timelines
+2 more records
Product overview1 text field

Diligent Pharma offers a platform-plus-modules architecture centered on Diligent360 as the core unified platform, supplemented by VendorBase (a global Vendor database) and Diligent Respond (an automated questionnaire tool). The core platform connects Sponsors and Vendors for risk-based Vendor discovery, qualification, and monitoring, while VendorBase provides the underlying data repository and Diligent Respond enables efficient Vendor questionnaire completion.

Product and service3 records
1Diligent360
CategoryClinical Trial Vendor Management Platform
Description

Centralized vendor management platform that connects pharmaceutical Sponsors and clinical trial Vendors, streamlining risk-based vendor discovery, qualification, and monitoring for clinical trials.

2VendorBase
CategoryClinical Vendor Database
Description

Extensive global database of clinical vendors with robust data on capabilities, experience, qualification, and compliance, featuring sponsors actively seeking partnerships.

3Diligent Respond
CategoryRFI / Questionnaire Automation
Description

Automated questionnaire tool that streamlines response management, helping clinical trial vendors complete RFI forms faster and with less effort while demonstrating ICH and regulatory compliance.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Veeva provides a broad suite of cloud software for life sciences, including Veeva Vault for quality, regulatory, and vendor information management. Comparable to Diligent Pharma because it serves the same pharma sponsor base for vendor and qualification content management, but at much greater scale and breadth.

TypeBroad incumbent
Description

IQVIA is a global CRO and life sciences technology provider offering clinical operations, data, and vendor management services. It is comparable as an incumbent that sponsors already rely on for clinical trial vendor oversight, posing a bundling threat to Diligent's narrow focus.

3Oracle Health Sciences (Clinical One)
TypeBroad incumbent
Description

Oracle's Clinical One platform unifies clinical trial operations including trial design, EDC, and vendor integrations. It is comparable because it targets the same pharma sponsor buyers and could absorb vendor qualification workflows into a single platform.

TypeBroad incumbent
Description

Medidata offers the Rave clinical cloud used by most large pharma sponsors for trial execution. Comparable to Diligent because it sits in the same sponsor clinical-operations stack and could extend into vendor qualification via integrations or product expansion.

TypeDirect peer
Description

Florence Healthcare connects sponsors and clinical trial sites through eISF and eRegulatory workflows. It is a direct peer because it addresses the same sponsor-vendor/site documentation and oversight burden that Diligent targets, though focused on sites rather than vendors.

TypeBroad incumbent
Description

Clario provides clinical trial endpoint technology and services used by pharma sponsors and CROs. Comparable because it serves the same clinical operations buyers and offers adjacent tools that overlap with sponsor-vendor workflow management.

TypeEmerging player
Description

Slope provides clinical trial supply and randomization technology to sponsors and vendors. Comparable as a venture-backed clinical-operations workflow vendor selling to the same pharma sponsor base that Diligent targets with its vendor qualification platform.

TypeEmerging player
Description

Vial operates a technology-enabled CRO platform that connects sponsors with clinical research vendors. Comparable because it shares the thesis of digitizing sponsor-vendor coordination in clinical trials, though Vial approaches from the CRO-services side.

TypeDirect peer
Description

RealTime offers CTMS, eRegulatory, and vendor/IRB workflow software to research sites and sponsors. Comparable to Diligent because it serves the sponsor-vendor operational layer of clinical trials with a SaaS platform and shared buyer personas.

TypeEmerging player
Description

Castor provides an eClinical platform used by sponsors and CROs for trial data capture and operations. Comparable as a venture-scale clinical operations SaaS vendor pursuing similar pharma sponsor customers and adjacent workflow modules.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Diligent Pharma

Clinical Trial Management Softwarediligentpharma.com

Diligent Pharma operates Diligent360, a centralized SaaS platform that connects pharmaceutical sponsors and clinical trial vendors for risk-based vendor discovery, qualification, and monitoring, supported by VendorBase (a global vendor database) and Diligent Respond (automated RFI questionnaire tool).

What Diligent Pharma does

Diligent Pharma is a Philadelphia- and Princeton, NJ-based private software company founded in 2018 that operates a centralized vendor qualification platform for the clinical trial industry. The company's core product, Diligent360, connects pharmaceutical sponsors and clinical trial vendors, streamlining risk-based vendor discovery, qualification, and monitoring. It is supplemented by VendorBase, a global database of clinical vendors with data on capabilities, experience, qualification, and compliance, and Diligent Respond, an automated questionnaire tool that helps vendors complete RFI forms faster while demonstrating ICH and regulatory compliance. SME-led risk scoring and a regulation-based RFI and Audit Report Library are positioned as the primary differentiators, with the company claiming reduction of vendor qualification timelines from months to days and significant audit hours saved for clients since 2021.

The business operates as an enterprise SaaS on a subscription/recurring revenue model, selling directly to pharmaceutical sponsors and clinical trial vendors through a 'Book a Demo' sales motion that signals quote-based, large-ACV contracts rather than self-serve SMB volume. Pricing is not publicly disclosed. The customer base is segmented vertically — sponsors seeking to mitigate trial risk and shorten start-up timelines, and vendors seeking faster qualification and broader sponsor exposure — addressing pain points such as lengthy qualification cycles, fragmented vendor oversight, and compliance with ICH and global regulatory standards. The company maintains a content marketing and blog presence for top-of-funnel engagement and funnels prospects into demo-driven bottom-of-funnel conversions.

Diligent Pharma completed an $8.27 million Series A financing round in May 2023 led by FCA Venture Partners, with additional participation from PJC and GenHenn Capital. The funding was directed toward expanding the company's data and content strategy for streamlining vendor qualification in clinical trial execution. The company operates with 11-50 employees, is led by founder Patricia Leuchten and President LeRoy Jones, and is incorporated as Diligent Pharma Inc. in the United States. No revenue, ARR, or named customer logos are publicly disclosed.

Diligent Pharma firmographics

Firmographics
Name
Diligent Pharma
Legal name
Diligent Pharma Inc.
Website
https://diligentpharma.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Diligent Pharma operates Diligent360, a centralized SaaS platform that connects pharmaceutical sponsors and clinical trial vendors for risk-based vendor discovery, qualification, and monitoring, supported by VendorBase (a global vendor database) and Diligent Respond (automated RFI questionnaire tool).
Ownership category
akta.pro rank

Diligent Pharma industry classification

Industry
Product category
Clinical Trial Management Software
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAOAH
Clinical Trial Supply, Logistics & Vendor Management FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Clinical trial vendor qualification
  • Clinical trial management software
  • Pharmaceutical vendor management
  • Clinical vendor database
  • RFI management software

Where Diligent Pharma is headquartered

Location

Headquarters

HQ city
Princeton
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Diligent Pharma business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Platform Subscription: SaaS-based platform access for sponsors and vendors. The company operates as a private vendor qualification organization providing centralized vendor management solutions for clinical trial management.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Diligent Pharma product offering

Product offering

Core offering

Diligent Pharma provides a centralized SaaS platform (Diligent360) that connects pharmaceutical sponsors and clinical trial vendors, streamlining risk-based vendor discovery, qualification, and monitoring for clinical trials. The offering is complemented by VendorBase, a global database of clinical vendors with capabilities and compliance data, and Diligent Respond, an automated questionnaire tool that helps vendors complete RFI forms faster.

Product overview

Diligent Pharma offers a platform-plus-modules architecture centered on Diligent360 as the core unified platform, supplemented by VendorBase (a global Vendor database) and Diligent Respond (an automated questionnaire tool). The core platform connects Sponsors and Vendors for risk-based Vendor discovery, qualification, and monitoring, while VendorBase provides the underlying data repository and Diligent Respond enables efficient Vendor questionnaire completion.

Differentiator

Problem solved

Functional benefit

Brands

  • Diligent360: Centralized platform that connects Sponsor and Vendors, streamlining risk-based Vendor discovery, qualification, and monitoring for clinical trials
  • VendorBase
  • Diligent Respond

Products and services

  • Diligent360 Centralized vendor management platform that connects pharmaceutical Sponsors and clinical trial Vendors, streamlining risk-based vendor discovery, qualification, and monitoring for clinical trials.
  • VendorBase Extensive global database of clinical vendors with robust data on capabilities, experience, qualification, and compliance, featuring sponsors actively seeking partnerships.
  • Diligent Respond Automated questionnaire tool that streamlines response management, helping clinical trial vendors complete RFI forms faster and with less effort while demonstrating ICH and regulatory compliance.

Quantifiable outcome

  • 3-5 months reduction in qualification timelines
  • +2 more outcomes

Companies that use Diligent Pharma

Customer profile

Segments2 records

Ideal customer profiles2 records

Diligent Pharma technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Diligent Pharma partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Diligent Pharma competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Veeva provides a broad suite of cloud software for life sciences, including Veeva Vault for quality, regulatory, and vendor information management. Comparable to Diligent Pharma because it serves the same pharma sponsor base for vendor and qualification content management, but at much greater scale and breadth.
  • IQVIA: IQVIA is a global CRO and life sciences technology provider offering clinical operations, data, and vendor management services. It is comparable as an incumbent that sponsors already rely on for clinical trial vendor oversight, posing a bundling threat to Diligent's narrow focus.
  • Oracle Health Sciences (Clinical One): Oracle's Clinical One platform unifies clinical trial operations including trial design, EDC, and vendor integrations. It is comparable because it targets the same pharma sponsor buyers and could absorb vendor qualification workflows into a single platform.
  • Medidata (Dassault Systèmes): Medidata offers the Rave clinical cloud used by most large pharma sponsors for trial execution. Comparable to Diligent because it sits in the same sponsor clinical-operations stack and could extend into vendor qualification via integrations or product expansion.
  • Clario: Clario provides clinical trial endpoint technology and services used by pharma sponsors and CROs. Comparable because it serves the same clinical operations buyers and offers adjacent tools that overlap with sponsor-vendor workflow management.

Direct peers

  • Florence Healthcare: Florence Healthcare connects sponsors and clinical trial sites through eISF and eRegulatory workflows. It is a direct peer because it addresses the same sponsor-vendor/site documentation and oversight burden that Diligent targets, though focused on sites rather than vendors.
  • RealTime Software Solutions: RealTime offers CTMS, eRegulatory, and vendor/IRB workflow software to research sites and sponsors. Comparable to Diligent because it serves the sponsor-vendor operational layer of clinical trials with a SaaS platform and shared buyer personas.

Emerging players

  • Slope (formerly 4G Clinical): Slope provides clinical trial supply and randomization technology to sponsors and vendors. Comparable as a venture-backed clinical-operations workflow vendor selling to the same pharma sponsor base that Diligent targets with its vendor qualification platform.
  • Vial: Vial operates a technology-enabled CRO platform that connects sponsors with clinical research vendors. Comparable because it shares the thesis of digitizing sponsor-vendor coordination in clinical trials, though Vial approaches from the CRO-services side.
  • Castor: Castor provides an eClinical platform used by sponsors and CROs for trial data capture and operations. Comparable as a venture-scale clinical operations SaaS vendor pursuing similar pharma sponsor customers and adjacent workflow modules.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Diligent Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Diligent Pharma leadership team

Management profile

Number of profiles

Profiles2 records

Diligent Pharma funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Diligent Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diligent Pharma

What does Diligent Pharma do?

Diligent Pharma provides a centralized SaaS platform (Diligent360) that connects pharmaceutical sponsors and clinical trial vendors, streamlining risk-based vendor discovery, qualification, and monitoring for clinical trials. The offering is complemented by VendorBase, a global database of clinical vendors with capabilities and compliance data, and Diligent Respond, an automated questionnaire tool that helps vendors complete RFI forms faster.

Is Diligent Pharma a public or private company?

Diligent Pharma is a private company. It is classified as venture growth investor backed and is currently operating.

When was Diligent Pharma founded?

Diligent Pharma was founded in 2018. It employs 11 to 50 people.

Where is Diligent Pharma based?

Diligent Pharma is headquartered in Princeton, United States, in the North America region.

How does Diligent Pharma make money?

One revenue line is on record: platform Subscription.

Who are Diligent Pharma's main competitors?

Broad incumbents on record are Veeva Systems, IQVIA, Oracle Health Sciences (Clinical One), Medidata (Dassault Systèmes) and Clario. Direct peers are Florence Healthcare and RealTime Software Solutions. Emerging players are Slope (formerly 4G Clinical), Vial and Castor.

Does Diligent Pharma have an API?

No public API is recorded for Diligent Pharma.

What industry is Diligent Pharma in?

Diligent Pharma's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLAGAOAH, Clinical Trial Supply, Logistics & Vendor Management FSP, with a secondary code of HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogDiligent Pharma, Inc. Announces Completion of $8.27 Million Series A Financing RaisedDiligent Pharma, Inc. completed an $8.27 million Series A financing round, led by FCA Venture Partners, along with participation from PJC and GenHenn Capital. The funds will be used to scale the company's data and content strategy to improve clinical trial execution. The CEO expressed optimism about the partnership and the potential for growth in the organization.BioSpaceDiligent Pharma, Inc. Announces Completion of $8.27 Million Series A Financing RaisedDiligent Pharma Inc. announced the closing of an $8.27 million Series A financing round led by FCA Venture Partners, with participation from PJC and GenHenn Capital. The funding will support the company's strategy to scale its data and content capabilities for its centralized vendor qualification platform in clinical trials.FinSMEsDiligent Pharma Closes $8.27M Series A FinancingDiligent Pharma, a Princeton-based vendor qualification and risk management organization, closed an $8.27 million Series A financing round led by FCA Venture Partners with participation from PJC and GenHenn Capital. The company plans to utilize the funds to scale its data and content strategy for streamlining vendor qualification in clinical trials.ZapierDiligent Pharma, Inc. Announces Completion of $8.27 Million Series A Financing RaisedDiligent Pharma, Inc. announced the closing of an $8.27 million Series A financing round led by FCA Venture Partners, with participation from PJC and GenHenn Capital. The funding is designated to support the company's scaling of its data and content strategy for its clinical trial vendor qualification platform.DiligentpharmaDiligent Pharma, Inc. Announces Completion of $8.27 Million Series A Financing RaisedDiligent Pharma, Inc. announced the completion of an $8.27 million Series A financing round led by FCA Venture Partners, with additional participation from PJC and GenHenn Capital. The funding is designated to support the company's scaling of data and content strategies for its vendor qualification platform in clinical trials.VC News DailyDiligent Pharma Completes $8.27 Million Series ADiligent Pharma Inc, a vendor qualification and risk management organization serving clinical trial execution, has closed an $8.27 million Series A financing round. The round was led by FCA Venture Partners with participation from PJC, GenHenn Capital, and private investors. The funding will support the company's growth as a provider of centralized technology platforms for streamlining vendor qualification in clinical trials.Business Wire BlogDiligent Pharma, Inc. Announces Completion of $8.27 Million Series A Financing RaisedDiligent Pharma completed an $8.27 million Series A financing round led by FCA Venture Partners, with additional investors including PJC and GenHenn Capital. The funding will support scaling its data and content strategy for vendor qualification in clinical trials. The company aims to drive speed, quality, and risk mitigation in clinical trial execution.